Hunault-Berger, M <br/><br/>
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.  [electronic resource] 

 -  Leukemia  Jun 2001 
 - 898-902 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2402130  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Asparaginase--administration & dosage<br/>Bone Marrow Transplantation<br/>Carmustine--administration & dosage<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Gram-Negative Bacterial Infections--etiology<br/>Humans<br/>Immunocompromised Host<br/>Infusions, Intravenous<br/>Injections, Intravenous<br/>Life Tables<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Prednisone--administration & dosage<br/>Remission Induction<br/>Survival Analysis<br/>Thrombocytopenia--chemically induced<br/>Treatment Outcome<br/>Vincristine--administration & dosage